Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies by Tara Murty, Jonathan H. Lin, Prithvi Mruthyunjaya

Subjects: Get full text

AXL and SRC in clear cell renal cell carcinoma: absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosis by Muriel D Brada, Tülay Karakulak, Peter Schraml, Martina Haberecker, Dorothea Rutishauser, Jeffrey S Ross, Daniel Eberli, Holger Moch

Subjects: Get full text

The prognostic impact of surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: a single center real-world retrospective study by Yanzhen Yang, Yanzhen Yang, Qu Xie, Qu Xie, Chuankai Shang, Chuankai Shang, Lai Jiang, Guojun Ding, Dan Long, Cong Luo

Subjects: Get full text

Tyrosine Kinase Inhibitor Post-Allogeneic Stem Cell Transplantation in Adult Philadelphia-Positive B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions by Martina Canichella, Paolo de Fabritiis

Subjects: Get full text

Combination Therapy With MET Tyrosine Kinase Inhibitor and EGFR Tyrosine Kinase Inhibitor in Patients With MET-Overexpressed EGFR-Mutant Lung Adenocarcinoma by Jia-Jun Wu, MD, Zhe-Rong Zheng, MD, Tse-Hsien Lo, MD, Cheng-Hsiang Chu, MD, Kun-Chieh Chen, MD, PhD, Gee-Chen Chang, MD, PhD

Subjects: Get full text

Ibrutinib-associated osteonecrosis of the jaw by Annu Singh, Sion Na, Joseph M. Huryn, Cherry L. Estilo, Steven Horwitz, SaeHee K. Yom

Subjects: Get full text

Case Report: Severe brigatinib-induced pneumonitis in a patient with EML4–ALK+ metastatic non-small cell lung adenocarcinoma by Khyati Somayaji Dasika, Megan Melody, Jyoti D. Patel

Subjects: Get full text

Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-C... by Mélissa Julien, Léa Pierre, Anne-Cécile Gérout, Laurent Sattler, Olivier Feugeas, Dominique Desprez

Subjects: Get full text

Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancer by Leslie Cheng, Syeda Khadijah Ghaznavi, Jessica Stevens, Sonja Hoy, Kee Howe Wong, Tass Malik, Kate Newbold, Daniel Morganstein

Subjects: Get full text

COVID-19 infection in patients with chronic myeloid leukemia in the Orenburg region during the SARS-CoV-2 pandemic by G. B. Kuchma, U. A. Yakubova, L. K. Kozlova, S. A. Lebedenko, F. R. Sayfutdinov

Subjects: Get full text

Priapism as the first symptom of chronic myeloid leukemia: literature review and own clinical case report by T. Yu. Pavlova, T. T. Valiev

Subjects: Get full text

Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd‐Generation Bruton Tyrosine Kinase Inhibitor‐Based Therapies by Benjamin J. Lee, Jenny Liu, Shawn P. Griffin, Jean Doh, Stefan O. Ciurea, Piyanuch Kongtim, Elizabeth A. Brem

Subjects: Get full text

Effectiveness of systemic treatments for advanced non-clear cell renal cell carcinoma: a systematic review and meta-analysis by Yaping Zhang, Jian Chen, Xiaoyan Wang, Hui Wang, Xiaoli Chen, Jianfeng Hong, Hongming Fang

Subjects: “…vascular endothelial growth factor receptor tyrosine kinase inhibitors…”
Get full text

Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhi... by Yaxiong Zhang, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Ningning Zhou, Likun Chen, Ting Zhou, Gang Chen, Shen Zhao, Huaqiang Zhou, Hui Li, Xiaoyan Kang, Li Zhang, Wenfeng Fang

Subjects: Get full text

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy by Anna De Lucia, Lucia Mazzotti, Lucia Mazzotti, Anna Gaimari, Anna Gaimari, Matteo Zurlo, Roberta Maltoni, Claudio Cerchione, Sara Bravaccini, Angelo Delmonte, Lucio Crinò, Patricia Borges de Souza, Luigi Pasini, Fabio Nicolini, Fabrizio Bianchi, Manel Juan, Hugo Calderon, Chiara Magnoni, Chiara Magnoni, Luca Gazzola, Luca Gazzola, Paola Ulivi, Massimiliano Mazza

Subjects: Get full text

Mammary analogue secretory carcinoma of the salivary gland with NTRK fusions: new approaches for diagnostics and targeted therapy (review) by A. V. Ignatova, A. M. Mudunov, S. О. Podvyaznikov, Yu. V. Alymov

Subjects: Get full text

A Possible Association between Deep Molecular Response and Combination of Tyrosine Kinase Inhibitor and Immunochemotherapy in a Patient with Coexisting Chronic Myeloid Leukemia and... by Wen-Yung Tsai, Cih-En Huang

Subjects: Get full text

Incidence Status and Factors Associated With Tyrosine Kinase Inhibitor‐Induced Hypertension in Patients With Renal Cell Carcinoma by Satoru Nakanishi, Keisuke Ikegami, Shungo Imai, Hayato Kizaki, Satoko Hori

Subjects: Get full text

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients by Anastasia Putri, Ikhwan Rinaldi, Melva Louisa, Soekamto Koesnoe

Subjects: Get full text

Anti-angiogenic tyrosine kinase inhibitors and the pathophysiology of their toxic effects: revisiting the treatment of anemia in metastatic cancers by Tai Van Nguyen, Eurydice Angeli, Diaddin Hamdan, Morad El Bouchtaoui, Oanh T. Bui, Feriel Azibani, Rong Shen, He Lu, Kien Hung Do, Anne Janin, Quang Van Le, Guilhem Bousquet

Subjects: Get full text